# Tarsus Pharmaceuticals, Inc.: Form 8-K, filed Feb 18, 2026

- Company: [Tarsus Pharmaceuticals, Inc.](/companies/tars.md) (CIK 1819790)
- Form: 8-K
- Filed: 2026-02-18
- Accepted by EDGAR: Feb 18, 2026, 08:32 ET
- Period: 2026-02-18
- Accession: 0001819790-26-000005
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000005/tars-20260218.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1819790/000181979026000005/

## Items reported

- Item 5.02: Departure or appointment of officers or directors
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1819790/000181979026000005/tars-20260218.htm

Filed Feb 18, 2026.
Source: SEC EDGAR, the filing index for accession 0001819790-26-000005. Last ingested by Listed: Nov 14, 2026, 22:55 ET. No prices; not investment advice.
